Acute Myeloblastic Leukemia without Maturation

Search Trials
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Status:
Completed
Last Changed:
May 22, 2018
First Changed:
Apr 25, 2008
Disease(s):
Adult Acute Monoblastic Leukemia (M5a)
Intervention(s):
idarubicincytarabinebortezomibetoposidelaboratory biomarker analysis
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Mar 30, 2018
First Changed:
Feb 28, 2013
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
mitoxantrone hydrochloridecytarabineperipheral blood stem cell transplantationlaboratory biomarker analysis
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Aug 20, 2015
First Changed:
Dec 15, 2010
Disease(s):
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Intervention(s):
AzacitidineEtoposideLaboratory Biomarker AnalysisMitoxantrone Hydrochloride
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Mar 28, 2022
First Changed:
Apr 15, 2008
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AzacitidineGemtuzumab Ozogamicin
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
May 19, 2016
First Changed:
Jul 17, 2012
Disease(s):
Childhood Acute Monoblastic Leukemia (M5a)
Intervention(s):
laboratory biomarker analysis

Connect. Empower. Inspire.